SOURCE: CAPS, A B. Braun Company

CAPS, a B. Braun Company

June 10, 2016 17:31 ET

CAPS® and BD Form Collaboration to Provide Ready-to-Use, Pre-Filled Anesthesia Syringes for Use With the BD Intelliport™ Medication Management System

IRVINE, CA--(Marketwired - Jun 10, 2016) - Central Admixture Pharmacy Services, Inc. (CAPS) and BD (Becton, Dickinson and Company) (NYSE: BDX), today announced that they have entered into a collaboration agreement that will offer BD Intelliport™ Medication Management System customers the opportunity to purchase a portfolio of frequently used CAPS' pre-filled anesthesia syringes capable of being automatically identified and utilized by the BD Intelliport System for real-time patient safety checks and hands-free electronic medication documentation. 

Under the agreement, CAPS will offer a new service line of pharmacy-compounded, pre-filled anesthesia syringes compatible with the BD Intelliport System. For this new service line, BD, in turn, will grant CAPS a period of exclusivity to utilize syringes incorporating proprietary BD technology for enabling fully-automated medication and drug concentration identification during syringe connection to a BD Intelliport Injection Site.

CAPS' 503B-registered outsourcing facilities offer pre-filled anesthesia syringes designed to prevent common compounding and labeling errors that occur in the operating room, while maintaining sterility and potency for extended beyond use dating. The pre-filled anesthesia syringes are prepared in a controlled environment and have undergone release testing for sterility, potency and endotoxin to meet strict new FDA quality control requirements.

The BD Intelliport System is the first-of-its-kind solution to provide real-time medication identification, dose measurement and patient drug allergy alerting at the point of injection, while wirelessly sending captured information directly into the patient's electronic medical record (EMR) following medication administration.

"Anesthesiologists have the convenience of ready-to-use, pre-prepared medications that now can be combined with the BD Intelliport System for added patient safety and improved workflow," said Mike Koch, Senior Vice President, CAPS Professional Services. "CAPS has always insisted that patient safety drive our pharmacy service offerings, and becoming the exclusive outsourcing provider of pre-filled syringes for use with the innovative BD Intelliport System is an important step in meeting our companies' mutual goal of reducing patient errors."

"This collaboration with CAPS exemplifies BD's commitment to provide our customers with medication management solutions that will help clinicians deliver safer and more efficient care," said Richard Byrd, Vice President and General Manager for BD Medical - Medication & Procedural Solutions. "BD continuously seeks opportunities to help reduce medication errors and enabling this new CAPS offering of pre-filled anesthesia syringes compatible with the BD Intelliport System is yet another example of our dedication to greater medication safety."

About CAPS®
CAPS is the nation's largest network of outsourcing admixture pharmacies. A pioneer in the outsourcing of CSPs, CAPS was founded in 1991, and delivers high-quality, same-day, admixture services and solutions to hospitals and outpatient facilities across the nation. CAPS has two 503B Outsourcing Facilities that are registered with the FDA to provide anticipatory compounding services. CAPS also has 22 state licensed 503A regional pharmacies that dispense labeled, patient-specific prescriptions including PN and chemotherapy. To learn more, visit www.capspharmacy.com.

About BD
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, optimize respiratory care and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 45,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit bd.com.

Contact Information

  • Contact:
    Todd Jones
    Central Admixture Pharmacy Services, Inc.
    303.744.7713
    Email Contact